Register entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 3
- Countries
- 0
Exclusivity
Patents and exclusivities
3| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 9034300 | EXEM FOAM KITair polymer-type a | product | Oct 2030 |
| 9259494 | EXEM FOAM KITair polymer-type a | product | May 2035 |
| 9849199 | EXEM FOAM KITair polymer-type a | product | Feb 2036 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| ExEm Foam | Air Polymer-Type A Intrauterine Foam | kit, intrauterine | 73254-310NDA |
Enquiry
Common questions
- Is GISKIT PHARMA B.V. FDA approved?
- GISKIT PHARMA B.V. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does GISKIT PHARMA B.V. make?
- 1 product is listed under GISKIT PHARMA B.V. in the openFDA NDC Directory, most often as kit. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.